Press Releases.

Month Year

Month Year

Investor Alerts

December 19, 2017

Regulus Announces First-in-Human Dosing for Phase I Study of RGLS4326 for the Treatment of Autosomal Dominant Polycystic Kidney Disease
November 07, 2017

Regulus Reports Third Quarter 2017 Financial Results and Recent Events

Conference Call Today at 5:00 p.m. ET
October 31, 2017

Regulus to Provide Third Quarter 2017 Financial Results on November 7, 2017

Conference Call and Webcast to Follow
August 30, 2017

Regulus to Present at the 2017 Wells Fargo Healthcare Conference
August 08, 2017

Regulus to Present at the 2017 Wedbush PacGrow Healthcare Conference

Show per page